New interventions and therapies lead to a near doubling of survival of patients with acute lymphoblastic leukemia following relapse after transplants.
The first classification of childhood tumors separating them from adult cancers will be published as a "blue book" by the World Health Organization.
Study: Short-term, severe calorie restriction can reduce sugar and other substances in blood that may feed cancer cells and boost the antitumor immune response. A diet involving short-term, severe calorie restriction was safe and...
“Patient-centered” study seeks to assess quality of time that patients live by measuring the “treatment-free survival” outcome. A treatment combining two immunotherapies gave patients with advanced kidney cancer a longer time without subsequent treatment...
Aggressive treatments given to younger patients with B-cell non-Hodgkin lymphoma may leave them vulnerable to other diseases later in life, according to a study in the AACR journal Cancer Epidemiology, Biomarkers & Prevention.
High-poverty counties in the United States may lag far behind wealthier counties in eliminating cervical cancer, a study published in the AACR journal Cancer Epidemiology, Biomarkers & Prevention found.
The use of lymphocytes to attack tumors may be less effective if given after other treatments, study published in an AACR journal indicates. Sooner rather than later may be the best strategy for using...
Remetinostat, a topical therapy that works by inhibiting the expression of cancer-promoting genes, could reduce the need for surgical removal of many subtypes of basal cell carcinoma lesions.
Exercise, healthful diet, no smoking or drinking are correlated with lower risk for cancer even in people with higher risk based on their genetic makeup.
Recently published clinical trial results suggest that combining an investigational antibody therapy with chemotherapy may be an effective strategy for patients with relapsed disease.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 49,000 members worldwide drive progress against cancer.
Donate Now